2023
Human Papillomavirus Vaccination Status and Correlates Among Mid-Adult Women: Connecticut, USA, 2016–2019
Sheth S, Johnson N, Sullivan E, Torres A, Oliveira C, Niccolai L. Human Papillomavirus Vaccination Status and Correlates Among Mid-Adult Women: Connecticut, USA, 2016–2019. Journal Of Women's Health 2023, 33: 28-32. PMID: 37943625, PMCID: PMC10794823, DOI: 10.1089/jwh.2022.0456.Peer-Reviewed Original ResearchConceptsMid-adult womenVaccination statusHPV vaccinationHPV vaccineHuman Papillomavirus Vaccination StatusHPV vaccination statusHuman papillomavirus vaccinationAge 26 yearsHealth care providersCross-sectional surveyPapillomavirus vaccinationUnvaccinated womenVaccinated womenVaccine informationCare providersVaccinationAdult womenVaccineWomenBehavioral correlatesCorrelatesStatusPotential benefitsYearsParticipantsFailure to Complete Multidose Vaccine Series in Early Childhood.
Michels S, Niccolai L, Hadler J, Freeman R, Albers A, Glanz J, Daley M, Newcomer S. Failure to Complete Multidose Vaccine Series in Early Childhood. Pediatrics 2023, 152 PMID: 37489285, PMCID: PMC10389773, DOI: 10.1542/peds.2022-059844.Peer-Reviewed Original ResearchConceptsVaccine seriesVaccination patternsUS childrenAdditional vaccine doseEarly childhood immunizationVaccine dosePreventable diseaseChildhood immunizationSeries completionNumber of childrenSociodemographic factorsInsurance coverageStrong associationOptimal protectionEarly childhoodBinomial regressionChildrenDosesAssociationStructural barriersCoverage goalsVaccinationImmunizationA review of data systems for assessing the impact of HPV vaccination in selected high-income countries
Wang W, Kothari S, Khoury H, Niccolai L, Garland S, Sundström K, de Pouvourville G, Bonanni P, Chen Y, Franco E. A review of data systems for assessing the impact of HPV vaccination in selected high-income countries. Expert Review Of Vaccines 2023, 22: 161-179. PMID: 36576068, DOI: 10.1080/14760584.2023.2162505.Peer-Reviewed Original ResearchConceptsHigh-income countriesHPV vaccinationCervical cancer prevention policyCharacteristics of HPVHuman papillomavirus vaccinationCervical screening programmeEarly detection measuresCancer prevention policiesWorld Health OrganizationPapillomavirus vaccinationCervical cancerVaccination coverageDisease outcomeScreening programElimination effortsGlobal eliminationPrevention programsTreatment programData SystemVaccinationHealth OrganizationHPVTargeted reviewPrevention policiesUnited StatesClinical and Public Health Considerations for HPV Vaccination in Midadulthood: A Narrative Review
King L, Lewnard J, Niccolai L. Clinical and Public Health Considerations for HPV Vaccination in Midadulthood: A Narrative Review. Open Forum Infectious Diseases 2023, 10: ofad004. PMID: 36726535, PMCID: PMC9887268, DOI: 10.1093/ofid/ofad004.Peer-Reviewed Original ResearchHPV vaccinationHuman papillomavirusNarrative reviewHPV natural historyRecurrent respiratory papillomatosisPublic health considerationsRespiratory papillomatosisOropharyngeal cancerAnogenital wartsPrevious infectionCancer casesUS guidelinesVaccinationImportant causeNatural historyAvailable evidenceSexual behaviorPatientsHealth considerationsCancerCliniciansBroad implementationGreater awarenessWide variationPapillomatosis
2022
Messaging of Different Disease Outcomes for Human Papillomavirus Vaccination: A Systematic Review
Niccolai L, Johnson N, Torres A, Sullivan E, Hansen C. Messaging of Different Disease Outcomes for Human Papillomavirus Vaccination: A Systematic Review. Journal Of Adolescent Health 2022, 72: 334-343. PMID: 36529616, DOI: 10.1016/j.jadohealth.2022.10.018.Peer-Reviewed Original Research
2018
2465. A Pilot Program to Improve Human Papillomavirus Vaccination Status of Adolescents at a School-Based Health Center
Hansen C, North A, Moriarty-Daley A, Niccolai L. 2465. A Pilot Program to Improve Human Papillomavirus Vaccination Status of Adolescents at a School-Based Health Center. Open Forum Infectious Diseases 2018, 5: s739-s739. PMCID: PMC6254943, DOI: 10.1093/ofid/ofy210.2118.Peer-Reviewed Original ResearchSchool-based health centersPrimary care centersHPV vaccine uptakeHPV vaccineHPV vaccinationVaccination statusVaccine uptakeElectronic health recordsEligible patientsImmunization statusHealth centersHuman papillomavirus vaccine uptakeHuman Papillomavirus Vaccination StatusCommon electronic health recordHPV immunization statusHPV vaccine receiptHPV vaccination statusPilot programVaccine receiptCare centerVaccination servicesClinic staffImmunization recordsPatientsVaccination
2015
PHS112 Human Papillomavirus (HPV) Vaccination during well-Child visits in privately insured Males 9-21 years of age in the United States in 2012
Zhang D, Huang M, Kulkarni A, Niccolai L. PHS112 Human Papillomavirus (HPV) Vaccination during well-Child visits in privately insured Males 9-21 years of age in the United States in 2012. Value In Health 2015, 18: a266-a267. DOI: 10.1016/j.jval.2015.03.1551.Peer-Reviewed Original Research